{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:59Z","timestamp":1791005759903,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several studies reported a central role of the endothelin type A receptor (ETAR) in tumor progression leading to the formation of metastasis. Here, we investigated the in vitro and in vivo anti-tumor effects of the FDA-approved ETAR antagonist, Ambrisentan, which is currently used to treat patients with pulmonary arterial hypertension. In vitro, Ambrisentan inhibited both spontaneous and induced migration\/invasion capacity of different tumor cells (COLO-357 metastatic pancreatic adenocarcinoma, OvCar3 ovarian carcinoma, MDA-MB-231 breast adenocarcinoma, and HL-60 promyelocytic leukemia). Whole transcriptome analysis using RNAseq indicated Ambrisentan\u2019s inhibitory effects on the whole transcriptome of resting and PAR2-activated COLO-357 cells, which tended to normalize to an unstimulated profile. Finally, in a pre-clinical murine model of metastatic breast cancer, treatment with Ambrisentan was effective in decreasing metastasis into the lungs and liver. Importantly, this was associated with a significant enhancement in animal survival. Taken together, our work suggests a new therapeutic application for Ambrisentan in the treatment of cancer metastasis.<\/jats:p>","DOI":"10.1038\/s41598-020-72960-1","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T10:02:46Z","timestamp":1601287366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis"],"prefix":"10.1038","volume":"10","author":[{"given":"Lucy","family":"Kappes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba L.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Sommerlatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Plattfaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-3822","authenticated-orcid":false,"given":"Frank","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Gemoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-4521","authenticated-orcid":false,"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Altahrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Al-Sbiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoja M.","family":"Haneefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-7223","authenticated-orcid":false,"given":"Kholoud","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena F.","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia El","family":"Khawanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze-Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kerstein-Staehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Marschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Pitann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Attoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Fernandez-Cabezudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel K.","family":"al-Ramadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Cabral-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"72960_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2199","author":"JP Overington","year":"2006","unstructured":"Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there?. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/nrd2199 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72960_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(99)01431-5","author":"GA Gray","year":"2000","unstructured":"Gray, G. A., Battistini, B. & Webb, D. J. Endothelins are potent vasoconstrictors, and much more besides. Trends Pharmacol. Sci. https:\/\/doi.org\/10.1016\/S0165-6147(99)01431-5 (2000).","journal-title":"Trends Pharmacol. Sci."},{"key":"72960_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/147616","author":"T Elisa","year":"2015","unstructured":"Elisa, T. et al. Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis. J. Immunol. Res. https:\/\/doi.org\/10.1155\/2015\/147616 (2015).","journal-title":"J. Immunol. Res."},{"key":"72960_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nature11896","author":"AJ Venkatakrishnan","year":"2013","unstructured":"Venkatakrishnan, A. J. et al. Molecular signatures of G-protein-coupled receptors. Nature https:\/\/doi.org\/10.1038\/nature11896 (2013).","journal-title":"Nature"},{"key":"72960_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep34282","author":"T Square","year":"2016","unstructured":"Square, T., Jandzik, D., Cattell, M., Hansen, A. & Medeiros, D. M. Embryonic expression of endothelins and their receptors in lamprey and frog reveals stem vertebrate origins of complex Endothelin signaling. Sci. Rep. https:\/\/doi.org\/10.1038\/srep34282 (2016).","journal-title":"Sci. Rep."},{"key":"72960_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature https:\/\/doi.org\/10.1038\/332411a0 (1988).","journal-title":"Nature"},{"key":"72960_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.3.357","author":"WG Haynes","year":"1995","unstructured":"Haynes, W. G., Strachan, F. E. & Webb, D. J. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation https:\/\/doi.org\/10.1161\/01.CIR.92.3.357 (1995).","journal-title":"Circulation"},{"key":"72960_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3282c563de","author":"MM Hoosein","year":"2007","unstructured":"Hoosein, M. M. et al. Altered endothelin receptor subtypes in colorectal cancer. Eur. J. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1097\/MEG.0b013e3282c563de (2007).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"72960_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3546","author":"L Rosan\u00f2","year":"2013","unstructured":"Rosan\u00f2, L., Spinella, F. & Bagnato, A. Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/nrc3546 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"72960_CR10","first-page":"951","volume":"26","author":"P W\u00fclfing","year":"2005","unstructured":"W\u00fclfing, P. et al. Overexpression of endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt\u2013chloride induced hypoxia. Int. J. Oncol. 26, 951\u2013960 (2005).","journal-title":"Int. J. Oncol."},{"key":"72960_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9589-5","author":"M Smollich","year":"2008","unstructured":"Smollich, M. et al. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion. Breast Cancer Res. Treat. https:\/\/doi.org\/10.1007\/s10549-007-9589-5 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"72960_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22036","author":"S Nie","year":"2014","unstructured":"Nie, S. et al. Role of endothelin a receptor in colon cancer metastasis: in vitro and in vivo evidence. Mol. Carcinog. https:\/\/doi.org\/10.1002\/mc.22036 (2014).","journal-title":"Mol. Carcinog."},{"key":"72960_CR13","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2193","author":"E Asham","year":"2001","unstructured":"Asham, E. et al. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br. J. Cancer https:\/\/doi.org\/10.1054\/bjoc.2001.2193 (2001).","journal-title":"Br. J. Cancer"},{"key":"72960_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00232-015-9854-1","author":"N Cong","year":"2016","unstructured":"Cong, N., Li, Z., Shao, W., Li, J. & Yu, S. Activation of ETA receptor by endothelin-1 induces hepatocellular carcinoma cell migration and invasion via ERK1\/2 and AKT signaling pathways. J. Membr. Biol. https:\/\/doi.org\/10.1007\/s00232-015-9854-1 (2016).","journal-title":"J. Membr. Biol."},{"key":"72960_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-944","author":"JB Nelson","year":"1995","unstructured":"Nelson, J. B. et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. https:\/\/doi.org\/10.1038\/nm0995-944 (1995).","journal-title":"Nat. Med."},{"key":"72960_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.03.037","author":"JR Klinger","year":"2011","unstructured":"Klinger, J. R., Oudiz, R. J., Spence, R., Despain, D. & Dufton, C. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension. Am. J. Cardiol. https:\/\/doi.org\/10.1016\/j.amjcard.2011.03.037 (2011).","journal-title":"Am. J. Cardiol."},{"key":"72960_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.742510","author":"N Gali\u00e8","year":"2008","unstructured":"Gali\u00e8, N. et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-Blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.742510 (2008).","journal-title":"Circulation"},{"key":"72960_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687","author":"N Galie","year":"2015","unstructured":"Galie, N. et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1413687 (2015).","journal-title":"N. Engl. J. Med."},{"key":"72960_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2402","author":"JH Newman","year":"2007","unstructured":"Newman, J. H., Kar, S. & Kirkpatrick, P. Ambrisentan. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/nrd2402 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72960_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040291","author":"M Humbert","year":"2004","unstructured":"Humbert, M., Sitbon, O. & Simonneau, G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMra040291 (2004).","journal-title":"N. Engl. J. Med."},{"key":"72960_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1254\/jphs.13R02CR","volume":"123","author":"T Horinouchi","year":"2013","unstructured":"Horinouchi, T., Terada, K., Higashi, T. & Miwa, S. Endothelin receptor signaling: new insight into its regulatory mechanisms. J. Pharmacol. Sci. 123, 85\u2013101 (2013).","journal-title":"J. Pharmacol. Sci."},{"key":"72960_CR22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-289314","author":"F Schaffner","year":"2010","unstructured":"Schaffner, F. et al. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood https:\/\/doi.org\/10.1182\/blood-2010-06-289314 (2010).","journal-title":"Blood"},{"key":"72960_CR23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.667717","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated Repression of miR-125b. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M115.667717 (2015).","journal-title":"J. Biol. Chem."},{"key":"72960_CR24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0419","author":"HH Versteeg","year":"2008","unstructured":"Versteeg, H. H. et al. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0419 (2008).","journal-title":"Cancer Res."},{"key":"72960_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00167","author":"P Aryappalli","year":"2017","unstructured":"Aryappalli, P. et al. The IL-6\/STAT3 signaling pathway is an early target of manuka honey-induced suppression of human breast cancer cells. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2017.00167 (2017).","journal-title":"Front. Oncol."},{"key":"72960_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01764.x","author":"PV Soeiro-Pereira","year":"2012","unstructured":"Soeiro-Pereira, P. V. et al. BAY 41\u20132272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01764.x (2012).","journal-title":"Br. J. Pharmacol."},{"key":"72960_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07598-9","author":"O Cabral-Marques","year":"2018","unstructured":"Cabral-Marques, O. et al. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-018-07598-9 (2018).","journal-title":"Nat. Commun."},{"key":"72960_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.12.012","author":"J\u00c1 Nicol\u00e1s-\u00c1vila","year":"2017","unstructured":"Nicol\u00e1s-\u00c1vila, J. \u00c1, Adrover, J. M. & Hidalgo, A. Neutrophils in homeostasis, immunity, and cancer. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2016.12.012 (2017).","journal-title":"Immunity"},{"key":"72960_CR29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-259028","author":"J Pillay","year":"2010","unstructured":"Pillay, J. et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood https:\/\/doi.org\/10.1182\/blood-2010-01-259028 (2010).","journal-title":"Blood"},{"key":"72960_CR30","first-page":"5310","volume":"60","author":"F Vacca","year":"2000","unstructured":"Vacca, F., Bagnato, A., Catt, K. J. & Tecce, R. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res. 60, 5310\u20135317 (2000).","journal-title":"Cancer Res."},{"key":"72960_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000475","author":"AE Schafer","year":"2017","unstructured":"Schafer, A. E. & Blaxall, B. C. G protein coupled receptor-mediated transactivation of extracellular proteases. J. Cardiovasc. Pharmacol. https:\/\/doi.org\/10.1097\/FJC.0000000000000475 (2017).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"72960_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.07.002","author":"M K\u00f6se","year":"2017","unstructured":"K\u00f6se, M. GPCRs and EGFR\u2014cross-talk of membrane receptors in cancer. Bioorg. Med. Chem. Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.002 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"72960_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.01.001","author":"W Wang","year":"2018","unstructured":"Wang, W., Qiao, Y. & Li, Z. New insights into modes of GPCR activation. Trends Pharmacol. Sci. https:\/\/doi.org\/10.1016\/j.tips.2018.01.001 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"72960_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207278","author":"B Sch\u00e4fer","year":"2004","unstructured":"Sch\u00e4fer, B., Gschwind, A. & Ullrich, A. Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene https:\/\/doi.org\/10.1038\/sj.onc.1207278 (2004).","journal-title":"Oncogene"},{"key":"72960_CR35","first-page":"1486","volume":"58","author":"BA Pulaski","year":"1998","unstructured":"Pulaski, B. A. & Ostrand-Rosenberg, S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58, 1486\u20131493 (1998).","journal-title":"Cancer Res."},{"key":"72960_CR36","doi-asserted-by":"publisher","unstructured":"Pulaski, B. A. & Ostrand-Rosenberg, S. Mouse 4T1 breast tumor model. In Current Protocols in Immunology (Wiley, New York, 2001). https:\/\/doi.org\/10.1002\/0471142735.im2002s39.","DOI":"10.1002\/0471142735.im2002s39"},{"key":"72960_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2007.00539.x","author":"SA DuPr\u00e9","year":"2007","unstructured":"DuPr\u00e9, S. A., Redelman, D. & Hunter, K. W. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int. J. Exp. Pathol. https:\/\/doi.org\/10.1111\/j.1365-2613.2007.00539.x (2007).","journal-title":"Int. J. Exp. Pathol."},{"key":"72960_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0024-8","author":"RL Beijersbergen","year":"2020","unstructured":"Beijersbergen, R. L. Old drugs with new tricks. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-020-0024-8 (2020).","journal-title":"Nat. Cancer"},{"key":"72960_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-019-0018-6","author":"SM Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-019-0018-6 (2020).","journal-title":"Nat. Cancer"},{"key":"72960_CR40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8, N. et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1413687 (2015).","journal-title":"N. Engl. J. Med."},{"key":"72960_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22555","author":"S Takatsuki","year":"2013","unstructured":"Takatsuki, S. et al. Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension. Pediatr. Pulmonol. https:\/\/doi.org\/10.1002\/ppul.22555 (2013).","journal-title":"Pediatr. Pulmonol."},{"key":"72960_CR42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0574","author":"R Cartin-Ceba","year":"2011","unstructured":"Cartin-Ceba, R., Swanson, K., Iyer, V., Wiesner, R. H. & Krowka, M. J. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest https:\/\/doi.org\/10.1378\/chest.10-0574 (2011).","journal-title":"Chest"},{"key":"72960_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.069609","author":"RE Girgis","year":"2007","unstructured":"Girgis, R. E. et al. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/ard.2007.069609 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"72960_CR44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21341","author":"R Maffei","year":"2017","unstructured":"Maffei, R. et al. Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.21341 (2017).","journal-title":"Oncotarget"},{"key":"72960_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2016.01.009","author":"R Sestito","year":"2016","unstructured":"Sestito, R. et al. Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis. Life Sci. https:\/\/doi.org\/10.1016\/J.LFS.2016.01.009 (2016).","journal-title":"Life Sci."},{"key":"72960_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09387-4","author":"EJ Im","year":"2019","unstructured":"Im, E. J. et al. Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-019-09387-4 (2019).","journal-title":"Nat. Commun."},{"key":"72960_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.06.003","author":"A Haeger","year":"2015","unstructured":"Haeger, A., Wolf, K., Zegers, M. M. & Friedl, P. Collective cell migration: guidance principles and hierarchies. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2015.06.003 (2015).","journal-title":"Trends Cell Biol."},{"key":"72960_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2007.01696.x","author":"G Schulte","year":"2007","unstructured":"Schulte, G. & Levy, F. O. Novel aspects of G-protein-coupled receptor signalling? different ways to achieve specificity. Acta Physiol. https:\/\/doi.org\/10.1111\/j.1365-201X.2007.01696.x (2007).","journal-title":"Acta Physiol."},{"key":"72960_CR49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.763235","author":"NC Law","year":"2016","unstructured":"Law, N. C., White, M. F. & Hunzicker-Dunn, M. E. G protein-coupled receptors (GPCRs) that signal via protein kinase A (PKA) cross-talk at insulin receptor substrate 1 (IRS1) to activate the phosphatidylinositol 3-kinase (PI3K)\/AKT pathway. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M116.763235 (2016).","journal-title":"J. Biol. Chem."},{"key":"72960_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04432-0","author":"S Gulati","year":"2018","unstructured":"Gulati, S. et al. Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-018-04432-0 (2018).","journal-title":"Nat. Commun."},{"key":"72960_CR51","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1126\/science.1962211","volume":"254","author":"WJ Tang","year":"1991","unstructured":"Tang, W. J. & Gilman, A. G. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 254, 1500\u20131503 (1991).","journal-title":"Science"},{"key":"72960_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2741\/4707","volume":"24","author":"O Cabral-Marques","year":"2019","unstructured":"Cabral-Marques, O., Carvalho-Marques, A. H., Schimke, L. F., Heidecke, H. & Riemekasten, G. Loss of balance in normal GPCR-mediated cell trafficking. Front. Biosci. (Landmark Ed.) 24, 18\u201334 (2019).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"72960_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.134","author":"O Cabral-Marques","year":"2017","unstructured":"Cabral-Marques, O. & Riemekasten, G. Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases. Nat. Rev. Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2017.134 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72960_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/379557a0","author":"H Daub","year":"1996","unstructured":"Daub, H., Weiss, F. U., Wallasch, C. & Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature https:\/\/doi.org\/10.1038\/379557a0 (1996).","journal-title":"Nature"},{"key":"72960_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.08.024","author":"J Teoh","year":"2014","unstructured":"Teoh, J. et al. Endothelin-1\/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Cell. Signal. https:\/\/doi.org\/10.1016\/j.cellsig.2014.08.024 (2014).","journal-title":"Cell. Signal."},{"key":"72960_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/nrc990","author":"J Nelson","year":"2003","unstructured":"Nelson, J., Bagnato, A., Battistini, B. & Nisen, P. The endothelin axis: emerging role in cancer. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/nrc990 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"72960_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.01.078","author":"R Cianfrocca","year":"2014","unstructured":"Cianfrocca, R. et al. \u03b2-Arrestin 1 is required for endothelin-1-induced NF-\u03baB activation in ovarian cancer cells. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2014.01.078 (2014).","journal-title":"Life Sci."},{"key":"72960_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011241","author":"F Spinella","year":"2010","unstructured":"Spinella, F. et al. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1\u03b1 in melanoma cells. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0011241 (2010).","journal-title":"PLoS ONE"},{"key":"72960_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep40723","author":"X Cui","year":"2017","unstructured":"Cui, X. et al. NF-\u03ba B suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo. Sci. Rep. https:\/\/doi.org\/10.1038\/srep40723 (2017).","journal-title":"Sci. Rep."},{"key":"72960_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1187","author":"GL Semenza","year":"2003","unstructured":"Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/nrc1187 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"72960_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0216-7","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-019-0216-7 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"72960_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210421","author":"AS Dhillon","year":"2007","unstructured":"Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene https:\/\/doi.org\/10.1038\/sj.onc.1210421 (2007).","journal-title":"Oncogene"},{"key":"72960_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.524","author":"R Garg","year":"2014","unstructured":"Garg, R. et al. Protein kinase C and cancer: what we know and what we do not. Oncogene https:\/\/doi.org\/10.1038\/onc.2013.524 (2014).","journal-title":"Oncogene"},{"key":"72960_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203912","author":"RB Irby","year":"2000","unstructured":"Irby, R. B. & Yeatman, T. J. Role of Src expression and activation in human cancer. Oncogene https:\/\/doi.org\/10.1038\/sj.onc.1203912 (2000).","journal-title":"Oncogene"},{"key":"72960_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37625-0","author":"YL Liu","year":"2019","unstructured":"Liu, Y. L. et al. Assessing metastatic potential of breast cancer cells based on EGFR dynamics. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-37625-0 (2019).","journal-title":"Sci. Rep."},{"key":"72960_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07644-6","author":"A Kazi","year":"2018","unstructured":"Kazi, A. et al. GSK3 suppression upregulates \u03b2-catenin and c-Myc to abrogate KRas-dependent tumors. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-018-07644-6 (2018).","journal-title":"Nat. Commun."},{"key":"72960_CR67","doi-asserted-by":"publisher","unstructured":"Maguire, J. J. et al. Comparison of human ET A and ET B receptor signalling via G-protein and \u03b2-arrestin pathways. In Life Sciences (Pergamon, 2012). https:\/\/doi.org\/10.1016\/j.lfs.2012.03.021.","DOI":"10.1016\/j.lfs.2012.03.021"},{"key":"72960_CR68","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s3057","author":"B Casserly","year":"2008","unstructured":"Casserly, B. & Klinger, J. R. Ambrisentan for the treatment of pulmonary arterial hypertension. Drug Des. Dev. Ther. https:\/\/doi.org\/10.2147\/dddt.s3057 (2008).","journal-title":"Drug Des. Dev. Ther."},{"key":"72960_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2006.00063.x","author":"H Vatter","year":"2006","unstructured":"Vatter, H. & Seifert, V. Ambrisentan, a non-peptide endothelin receptor antagonist. Cardiovasc. Drug Rev. https:\/\/doi.org\/10.1111\/j.1527-3466.2006.00063.x (2006).","journal-title":"Cardiovasc. Drug Rev."},{"key":"72960_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4012-7","author":"S Vasaikar","year":"2018","unstructured":"Vasaikar, S. et al. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?. BMC Cancer https:\/\/doi.org\/10.1186\/s12885-018-4012-7 (2018).","journal-title":"BMC Cancer"},{"key":"72960_CR71","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.177703","author":"A Nair","year":"2016","unstructured":"Nair, A. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"72960_CR72","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42912","author":"N Said","year":"2011","unstructured":"Said, N., Smith, S., Sanchez-Carbayo, M. & Theodorescu, D. Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. J. Clin. Investig. https:\/\/doi.org\/10.1172\/JCI42912 (2011).","journal-title":"J. Clin. Investig."},{"key":"72960_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2008.01.008","author":"W-M Zhang","year":"2008","unstructured":"Zhang, W.-M., Zhou, J. & Ye, Q.-J. Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2008.01.008 (2008).","journal-title":"Life Sci."},{"key":"72960_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5536","author":"K Grant","year":"2007","unstructured":"Grant, K. et al. Mechanisms of endothelin 1-stimulated proliferation in colorectal cancer cell lines. Br. J. Surg. https:\/\/doi.org\/10.1002\/bjs.5536 (2007).","journal-title":"Br. J. Surg."},{"key":"72960_CR75","doi-asserted-by":"crossref","unstructured":"Tamkus, D., Sikorskii, A., Gallo, K. A., Wiese, D. A., Leece, C., Madhukar, B. V., Chivu, S. C., Chitneni, S. & Dimitrov, N. V. Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence. ISRN Oncol. (2013).","DOI":"10.1155\/2013\/385398"},{"key":"72960_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-69","author":"R Kefford","year":"2010","unstructured":"Kefford, R. et al. A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy. Mol. Cancer https:\/\/doi.org\/10.1186\/1476-4598-9-69 (2010).","journal-title":"Mol. Cancer"},{"key":"72960_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0089-9","author":"NF Pond\u00e9","year":"2019","unstructured":"Pond\u00e9, N. F., Zardavas, D. & Piccart, M. Progress in adjuvant systemic therapy for breast cancer. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-018-0089-9 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72960_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41626-y","author":"MG Chiorazzo","year":"2019","unstructured":"Chiorazzo, M. G. et al. Detection and differentiation of breast cancer sub-types using a cPLA2\u03b1 activatable fluorophore. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-41626-y (2019).","journal-title":"Sci. Rep."},{"key":"72960_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep31628","author":"C Vinayanuwattikun","year":"2016","unstructured":"Vinayanuwattikun, C. et al. Elucidating genomic characteristics of lung cancer progression from in situ to invasive adenocarcinoma. Sci. Rep. https:\/\/doi.org\/10.1038\/srep31628 (2016).","journal-title":"Sci. Rep."},{"key":"72960_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.026","author":"O Cabral-Marques","year":"2018","unstructured":"Cabral-Marques, O. et al. CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-\u03b3. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.026 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"72960_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11040","author":"F Gieseler","year":"2018","unstructured":"Gieseler, F. et al. Heterogeneity of microvesicles from cancer cell lines under inflammatory stimulation with TNF-\u03b1. Cell Biol. Int. https:\/\/doi.org\/10.1002\/cbin.11040 (2018).","journal-title":"Cell Biol. Int."},{"key":"72960_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169896","author":"F G\u00e4rtner","year":"2017","unstructured":"G\u00e4rtner, F., Abraham, G., Kassner, A., Baurichter, D. & Milting, H. Influence of mechanical circulatory support on endothelin receptor expression in human left ventricular myocardium from patients with dilated cardiomyopathy (DCM). PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0169896 (2017).","journal-title":"PLoS ONE"},{"key":"72960_CR83","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.1.496","author":"BK al-Ramadi","year":"2006","unstructured":"al-Ramadi, B. K., Fernandez-Cabezudo, M. J., Ullah, A., El-Hasasna, H. & Flavell, R. A. CD154 is essential for protective immunity in experimental salmonella infection: evidence for a dual role in innate and adaptive immune responses. J. Immunol. https:\/\/doi.org\/10.4049\/jimmunol.176.1.496 (2006).","journal-title":"J. Immunol."},{"key":"72960_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053087","author":"S Attoub","year":"2013","unstructured":"Attoub, S. et al. Frondoside A suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0053087 (2013).","journal-title":"PLoS ONE"},{"key":"72960_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.03.043","author":"AC de Almeida","year":"2011","unstructured":"de Almeida, A. C., Marques, O. C., Arslanian, C., Condino-Neto, A. & Ximenes, V. F. 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis. Eur. J. Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2011.03.043 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"72960_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1934-z","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-017-1934-z (2017).","journal-title":"BMC Bioinform."},{"key":"72960_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.018","author":"O Cabral-Marques","year":"2016","unstructured":"Cabral-Marques, O. et al. Human CD40L deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-\u03b3. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.018 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"72960_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24290-6","author":"M Hirose","year":"2018","unstructured":"Hirose, M. et al. Low-level mitochondrial heteroplasmy modulates DNA replication, glucose metabolism and lifespan in mice. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-24290-6 (2018).","journal-title":"Sci. Rep."},{"key":"72960_CR89","unstructured":"Babraham Bioinformatics\u2014FastQC a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"72960_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3519","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/nbt.3519 (2016).","journal-title":"Nat. Biotechnol."},{"key":"72960_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4324","author":"H Pimentel","year":"2017","unstructured":"Pimentel, H., Bray, N. L., Puente, S., Melsted, P. & Pachter, L. Differential analysis of RNA-seq incorporating quantification uncertainty. Nat. Methods https:\/\/doi.org\/10.1038\/nmeth.4324 (2017).","journal-title":"Nat. Methods"},{"key":"72960_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3901","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods https:\/\/doi.org\/10.1038\/nmeth.3901 (2016).","journal-title":"Nat. Methods"},{"key":"72960_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055993","author":"MJ Fernandez-Cabezudo","year":"2013","unstructured":"Fernandez-Cabezudo, M. J. et al. Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0055993 (2013).","journal-title":"PLoS ONE"},{"key":"72960_CR94","doi-asserted-by":"publisher","DOI":"10.3109\/17435390.2016.1163743","author":"KB Ramadi","year":"2016","unstructured":"Ramadi, K. B. et al. Acute systemic exposure to silver-based nanoparticles induces hepatotoxicity and NLRP3-dependent inflammation. Nanotoxicology https:\/\/doi.org\/10.3109\/17435390.2016.1163743 (2016).","journal-title":"Nanotoxicology"},{"key":"72960_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1543-x","author":"S Kaimala","year":"2014","unstructured":"Kaimala, S. et al. Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity. Cancer Immunol. Immunother. https:\/\/doi.org\/10.1007\/s00262-014-1543-x (2014).","journal-title":"Cancer Immunol. Immunother."},{"key":"72960_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00551","author":"RM Al-Barazie","year":"2018","unstructured":"Al-Barazie, R. M. et al. Cholinergic activation enhances resistance to oral Salmonella infection by modulating innate immune defense mechanisms at the intestinal barrier. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00551 (2018).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72960-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:39:44Z","timestamp":1670359184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72960-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72960"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72960-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15931"}}